Poly Medicure Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Poly Medicure heeft een totaal eigen vermogen van ₹14.7B en een totale schuld van ₹1.7B, wat de schuld-eigenvermogensverhouding op 11.8% brengt. De totale activa en totale passiva bedragen respectievelijk ₹18.6B en ₹3.9B. De EBIT Poly Medicure is ₹3.1B waardoor de rentedekking 25.6 is. Het heeft contanten en kortetermijnbeleggingen van ₹2.9B.
Belangrijke informatie
11.8%
Verhouding schuld/eigen vermogen
₹1.74b
Schuld
| Rente dekkingsratio | 25.6x |
| Contant | ₹2.86b |
| Aandelen | ₹14.70b |
| Totaal verplichtingen | ₹3.89b |
| Totaal activa | ₹18.59b |
Recente financiële gezondheidsupdates
Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14
Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25Recent updates
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00
Sep 14After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar
Sep 06Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138
Jul 27Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)
Jul 11Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹8.4B ) POLYMED } overtreffen de korte termijn passiva ( ₹3.5B ).
Langlopende schulden: De kortetermijnactiva POLYMED ( ₹8.4B ) overtreffen de langetermijnschulden ( ₹373.8M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: POLYMED heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van POLYMED is de afgelopen 5 jaar gedaald van 35.9% naar 11.8%.
Schuldendekking: De schuld van POLYMED wordt goed gedekt door de operationele kasstroom ( 152.8% ).
Rentedekking: De rentebetalingen op de schuld van POLYMED worden goed gedekt door EBIT ( 25.6 x dekking).